- Home
- KWE vs HSCS Comparison
KWE vs HSCS Comparison
Compare KWE & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KWE
- HSCS
- Stock Information
- Founded
- KWE 2017
- HSCS 2007
- Country
- KWE Canada
- HSCS United States
- Employees
- KWE N/A
- HSCS N/A
- Industry
- KWE
- HSCS Medical Specialities
- Sector
- KWE
- HSCS Health Care
- Exchange
- KWE Nasdaq
- HSCS Nasdaq
- Market Cap
- KWE 3.2M
- HSCS 3.7M
- IPO Year
- KWE N/A
- HSCS 2022
- Fundamental
- Price
- KWE $5.14
- HSCS $3.20
- Analyst Decision
- KWE
- HSCS Strong Buy
- Analyst Count
- KWE 0
- HSCS 2
- Target Price
- KWE N/A
- HSCS $13.00
- AVG Volume (30 Days)
- KWE 423.8K
- HSCS 13.2K
- Earning Date
- KWE 05-15-2025
- HSCS 03-13-2025
- Dividend Yield
- KWE N/A
- HSCS N/A
- EPS Growth
- KWE N/A
- HSCS N/A
- EPS
- KWE N/A
- HSCS N/A
- Revenue
- KWE $1,572,738.00
- HSCS N/A
- Revenue This Year
- KWE N/A
- HSCS N/A
- Revenue Next Year
- KWE N/A
- HSCS N/A
- P/E Ratio
- KWE N/A
- HSCS N/A
- Revenue Growth
- KWE 116.30
- HSCS 261.17
- 52 Week Low
- KWE $3.86
- HSCS $2.36
- 52 Week High
- KWE $243.60
- HSCS $13.50
- Technical
- Relative Strength Index (RSI)
- KWE 49.11
- HSCS 51.24
- Support Level
- KWE $0.22
- HSCS $2.97
- Resistance Level
- KWE $7.20
- HSCS $3.81
- Average True Range (ATR)
- KWE 0.64
- HSCS 0.35
- MACD
- KWE 0.17
- HSCS 0.02
- Stochastic Oscillator
- KWE 70.50
- HSCS 45.47
About KWE KWESST Micro Systems Inc.
KWESST Micro Systems Inc develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers and electronic detection.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.